News

STEM Clinical Trial

STEM Clinical Trial

Balt today announced the presentation of preliminary data from The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma during the late-breaking session at the International Stroke Conference in Phoenix, AZ. The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.

 

Discover the press release

Other News

News
Jan 09, 2024

BALT in the spotlight: media recognition for our stroke research work

Read More
BALT in the spotlight: media recognition for our stroke research work
News
Oct 08, 2023

Balt at the 20km of Paris

Read More
Balt at the 20km of Paris
News
May 20, 2023

Balt at Lisa Forever race

Read More
Balt at Lisa Forever race
News
Mar 08, 2023

Balt at the half marathon of Paris 2023

Read More
Balt at the half marathon of Paris 2023
News
Oct 18, 2022

French Government Grant for Research & Development

Read More
French Government Grant for Research & Development
News
Jun 15, 2022

John Allison joins Balt’s Executive Team

Read More
John Allison joins Balt’s Executive Team
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.

    *Required

    EN